Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6767572 | 6979753 | F | 6767572-3 | 20080101 | 20100601 | 20100614 | EXP | PHHY2009CA14356 | NOVARTIS PHARMACEUTICAL CORPORATION | 67 | YR | M | Y | 20100614 | OT | CANADA |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 6767572 | 1013857282 | PS | SANDOSTATIN LAR | 1 | INTRAMUSCULAR | 30 MG, QMO | 021008 | ||||
| 6767572 | 1013857283 | SS | SANDOSTATIN LAR | 1 | INTRAMUSCULAR | 40 MG, QMO | 021008 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 6767572 | 1013857282 | NEUROENDOCRINE TUMOUR |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 6767572 | HO |
Reactions reported
| Event ID | PT |
|---|---|
| 6767572 | ABDOMINAL PAIN |
| 6767572 | BLOOD POTASSIUM INCREASED |
| 6767572 | BLOOD PRESSURE SYSTOLIC INCREASED |
| 6767572 | CHOLECYSTECTOMY |
| 6767572 | CHOLECYSTITIS INFECTIVE |
| 6767572 | CHOLELITHIASIS |
| 6767572 | DIARRHOEA |
| 6767572 | HEPATIC EMBOLISATION |
| 6767572 | HEPATIC LESION |
| 6767572 | MALIGNANT NEOPLASM PROGRESSION |
| 6767572 | NAUSEA |
| 6767572 | VOMITING |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 6767572 | 1013857282 | 20080320 | 20091223 | 644 | DAY |